OntologiesCurators at RGD make annotations to genes, QTLs and strains using standardized vocabularies/ontologies. Your search returned annotations to the terms below.ChEBI: ChEBI Ontology
(2-methyl-4,5-ditridecyl-1,4-cyclohexadienyl)methanol
(2R,3R,4R)-2-[(2S,3R,4R,5R,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-2-carboxy-6-[(2S,3R,4S,5S,6R)-3,5-dihydroxy-2-[(2R,3S,4R,5R,6R)-5-hydroxy-2-(hydroxymethyl)-3-sulfooxy-6-[(2R,3R,4S)-1,3,4,5-tetrahydroxypentan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-6-(hydroxymethyl)-5-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
(2R,3S,4S,5R,6S)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-(1H-indol-3-yloxy)oxane-3,4,5-triol
(6S,7R,7aS)-6,7-dihydroxy-3,6-dimethyl-3,3a,4,5,7,7a-hexahydro-1-benzouran-2-one
1,4-Dimethoxyglucobrassicin
1-Furfurylpyrrolidine
18-deoxy-21-oxo-deacetyl-19,20-epoxycytochalasin N
2,3-Secoporrigenin
2-(3-nitroanilino)-N-[(5-nitro-2-furanyl)methylideneamino]acetamide
2-chloro-2'-hydroxy-4'-methylbenzophenone
3-p-Coumaroyl-1,5-quinolactone
4-hydroxymethyl-2-methoxyphenyl-1-O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside
4-p-Coumaroyl-1,5-quinolactone
5,5-Diisopropyl-2,2'-dimethylbiphenyl-3,3',4,4'-tetrone
5-hydroxy-9-methylstreptimidone
Arg-Asp-Leu
EC 2.1.3.3 (ornithine carbamoyltransferase) inhibitor
ent-kaur-16-en-19-oate
ent-kaur-16-en-19-oic acid
N-[(4R,7R,8R)-5-(2-cyclopropyl-1-oxoethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8S)-5-(2-cyclopropyl-1-oxoethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8R)-5-(2-cyclopropyl-1-oxoethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8S)-5-(2-cyclopropyl-1-oxoethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-5-(2-cyclopropyl-1-oxoethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8S)-5-(2-cyclopropyl-1-oxoethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8R)-5-(2-cyclopropyl-1-oxoethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8S)-5-(2-cyclopropyl-1-oxoethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-acetyl-D-aspartate(2-)
N-Acetyl-DL-aspartic acid
N-acetyl-L-aspartate(2-)
N-acetyl-L-aspartic acid
N-acetyl-L-aspartic acid-1,2,3,4-(13)C4
ochratoxin C
Oxytetracycline hydrochloride
PC(20:4(8Z,11Z,14Z,17Z)/22:0)
Streptophenazine R
Takinolide dimer
trans-4-p-coumaroylquinic acid
trans-5-O-(4-coumaroyl)-D-quinate
trans-5-O-(4-coumaroyl)-D-quinic acid
Xanthorhamnin
EFO: Experimental Factor Ontology
C syndrome
N-acetyl-L-aspartate(2-)
N-acetyl-L-aspartic acid
ornithine carbamoyltransferase deficiency
ornithine transcarbamylase, mitochondrial
ornithine transcarbamylase, mitochondrial (human)
OTC (human)
GO: Cellular Component
ornithine carbamoyltransferase inhibitor complex
GO: Molecular Function
ornithine carbamoyltransferase activity
MP: Mammalian Phenotype
abnormal ornithine carbamoyltransferase activity
decreased ornithine carbamoyltransferase activity
increased ornithine carbamoyltransferase activity
PW: Pathway Ontology
orotic aciduria pathway
RDO: RGD Disease Ontology
C syndrome
ornithine carbamoyltransferase deficiency
|
|||||||||||||||||||||||||||||||||||||||||||||||||||



















